Literature DB >> 23022650

Malignant peripheral nerve sheath tumor of the abducens nerve and a review of the literature.

Jason Voorhies1, Eyas M Hattab, Aaron A Cohen-Gadol.   

Abstract

BACKGROUND: Malignant peripheral nerve sheath tumors are rare, and intracranial occurrences are even more rare. Treatment strategies have varied widely. This article reports the first case of a malignant peripheral nerve sheath tumor of the abducens nerve and provides a literature review that includes 61 cases of intracranial malignant peripheral nerve sheath tumors. Data were analyzed based on age, sex, treatment, survival, immunohistochemical staining, location, tumor grade, and neurofibromatosis association. These tumors more often affect male persons, and the patients affected have a mean age of 39 years. Most patients underwent subtotal or gross total resection and radiation. Intracranial location varied, but most tumors occurred in the cerebellopontine angle. The literature shows that intracranial malignant peripheral nerve sheath tumors are a heterogeneous group. Their association with neurofibromatosis is less clear than that of their extracranial counterparts. Prognosis is poor, but surgical resection and radiation can enhance chances for longer survival. Our aim was to elucidate information about these tumors. CASE DESCRIPTION: A 30-year-old woman presented with a 6-month history of headaches and diplopia.
RESULTS: Neurological examination revealed no focal deficit. Imaging revealed a heterogeneously enhancing retroclival mass without bony destruction. The tumor originated from the ipsilateral abducens nerve and extended into the Dorello canal; it adhered to the brainstem and cranial nerves. Pathology was consistent with low-grade malignant peripheral nerve sheath tumor.
CONCLUSIONS: At 3-month follow-up, the patient walked with a cane with no further deficits except mild ataxia, which resolved within 6 months. Magnetic resonance imaging revealed a small residual tumor adherent to the basilar artery. At 1-year follow-up and after ocular surgery to correct lateral rectus palsy, the patient was neurologically intact.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abducens nerve; CN; CPA; Cerebellopontine angle; Cranial nerve; GTR; Gross total resection; MPNST; MRI; Magnetic resonance imaging; Malignant peripheral nerve sheath tumor; Malignant peripheral nerve sheath tumors; NF; Neurofibromatosis; Radiation; Surgical resection

Mesh:

Year:  2012        PMID: 23022650     DOI: 10.1016/j.wneu.2012.08.007

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  6 in total

1.  MALIGNANT TRANSFORMATION OF CRANIAL NERVE SCHWANNOMA AFTER RADIOSURGERY - CASE REPORT.

Authors:  A B Bah; O D N'dri; A Herbrecht; F Parker
Journal:  J West Afr Coll Surg       Date:  2014 Apr-Jun

Review 2.  Parotid Neurogenic Tumors: MPNST Sarcoma to Schwannoma-Review of Literature and Guidelines in Management.

Authors:  Srinivasa Rama Chandra; Shibani Das; Alejandro Wolf
Journal:  J Maxillofac Oral Surg       Date:  2021-03-23

3.  Intracranial malignant peripheral nerve sheath tumor variant: an unusual neurovascular phenotype sarcoma case invading through the petrous bone.

Authors:  Oliver D Mrowczynski; Robert J Greiner; Malika Kapadia; Julie C Fanburg-Smith; Mark R Iantosca; Elias B Rizk
Journal:  Childs Nerv Syst       Date:  2018-04-03       Impact factor: 1.475

4.  Malignant peripheral nerve sheath tumors of the head and neck: a case series and literature review.

Authors:  Brandon T Mullins; Trevor Hackman
Journal:  Case Rep Otolaryngol       Date:  2014-12-04

5.  Malignant Peripheral Nerve Sheath Tumor of the C2 Nerve Root: Case Report.

Authors:  Joshua D Burks; Robert G Briggs; Chad A Glenn; John C Greenert; Cordell M Baker; Keren Bartal; Greg A Krempl; Michael E Sughrue
Journal:  J Neurol Surg Rep       Date:  2017-04

6.  Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumors.

Authors:  Bénédicte L'heureux-Lebeau; Issam Saliba
Journal:  Onco Targets Ther       Date:  2013-04-26       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.